Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Roivant Sciences Ltd. - Common Shares
(NQ:
ROIV
)
26.52
-0.83 (-3.03%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 27, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
3,013,005
Open
27.26
Bid (Size)
21.28 (100)
Ask (Size)
28.03 (100)
Prev. Close
27.35
Today's Range
26.47 - 27.51
52wk Range
8.730 - 30.33
Shares Outstanding
692,072,184
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
A Healthcare Hedge Fund Just Added $24.5 Million in Immunovant Stock. Should you?
↗
March 15, 2026
This clinical-stage biotech develops antibody therapies targeting autoimmune diseases, with a lead candidate in Phase II trials.
Via
The Motley Fool
Moderna Settles High-Stakes LNP Patent War with $2.25 Billion Agreement
March 05, 2026
In a landmark resolution that removes a multi-year shadow over the messenger RNA (mRNA) industry, Moderna, Inc. (NASDAQ:MRNA) has reached a comprehensive $2.25 billion global settlement with Genevant...
Via
MarketMinute
Topics
Intellectual Property
Lawsuit
Performance
YTD
+21.0%
+21.0%
1 Month
-7.5%
-7.5%
3 Month
+19.3%
+19.3%
6 Month
+74.8%
+74.8%
1 Year
+153.1%
+153.1%
More News
Read More
BlackBarn Capital Builds Warby Parker Stake as the Direct-to-Consumer Eyewear Leader Expands Nationwide
↗
March 04, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Why Did Roivant Sciences Stock Gain 9% Pre-Market Today?
↗
February 06, 2026
Via
Stocktwits
Moderna-Arbutus-Genevant Patent Settlement: Wall Street Says Not Best-Case Scenario But Removes Overhang For MRNA Stock
↗
March 04, 2026
Via
Stocktwits
Topics
Intellectual Property
MRNA Shares Rally After Hours On Inking Settlement Deal Over Vaccine Patent Row
↗
March 03, 2026
Via
Stocktwits
Topics
Intellectual Property
Genevant Sciences and Arbutus Biopharma Announce $2.25 Billion Global Settlement With Moderna
March 03, 2026
From
Arbutus Biopharma Corporation
Via
GlobeNewswire
Roivant Announces Genevant Sciences’ and Arbutus Biopharma’s $2.25 Billion Global Settlement With Moderna
March 03, 2026
From
Roivant Sciences
Via
GlobeNewswire
Priovant Announces FDA Acceptance and Priority Review of New Drug Application for Brepocitinib in Dermatomyositis
March 03, 2026
From
Roivant Sciences
Via
GlobeNewswire
Celcuity Stock Soars 700% in a Year as One Investor's $17 Million Buy Helps Create Top Two Position
↗
February 22, 2026
Via
The Motley Fool
Apogee Shares Up Nearly 100% in 12 Months, and This $62 Million Buy Signals Ongoing Conviction
↗
February 22, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Dolby Stock Down 18%, Yet This $8 Million Bet Signals Turnaround Potential
↗
February 13, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
TTMI Stock Soars 250% in One Year, and One Fund Is Betting $7 Million on More Growth
↗
February 13, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Supply Chain
Healthcare REIT Posts 16.4% NOI Growth as Shares Soar 93%: Why This Fund's New Stake Stands Out
↗
February 13, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
The market is filled with gapping stocks in Friday's session.
↗
February 06, 2026
Via
Chartmill
Roivant Sciences (ROIV): Anatomy of a 15% Surge and the Future of the ‘Vant’ Model
February 06, 2026
Via
Finterra
Topics
ETFs
Economy
Initial Public Offering
Get insights into the top gainers and losers of Friday's pre-market session.
↗
February 06, 2026
Via
Chartmill
Roivant Announces Positive Phase 2 Results for Brepocitinib in Cutaneous Sarcoidosis (CS) and Reports Financial Results for the Third Quarter Ended December 31, 2025
February 06, 2026
From
Roivant Sciences
Via
GlobeNewswire
Pulmovant Announces Completion of Enrollment in the Phase 2 PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)
February 06, 2026
From
Pulmovant, Inc.
Via
GlobeNewswire
Priovant Announces Positive Phase 2 Results for Brepocitinib in Cutaneous Sarcoidosis (CS)
February 06, 2026
From
Roivant Sciences
Via
GlobeNewswire
The Great Rotation: Russell 2000’s Historic 15-Day Streak Marks a Seismic Shift in Market Leadership
January 26, 2026
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Economy
Roivant to Report Financial Results for the Third Quarter Ended December 31, 2025, and Provide Business Update on Friday, February 6, 2026
January 23, 2026
From
Roivant Sciences
Via
GlobeNewswire
Roivant Signals Major Pipeline Momentum With Accelerated Timelines
↗
December 11, 2025
Via
Benzinga
Roivant Highlights Continued Pipeline Progress and Outlook for Company’s Next Phase of Growth at 2025 Investor Day
December 11, 2025
From
Roivant Sciences
Via
GlobeNewswire
Roivant (ROIV) Q2 2026 Earnings Call Transcript
↗
November 27, 2025
Via
The Motley Fool
Topics
Earnings
Frequently Asked Questions
Is Roivant Sciences Ltd. - Common Shares publicly traded?
Yes, Roivant Sciences Ltd. - Common Shares is publicly traded.
What exchange does Roivant Sciences Ltd. - Common Shares trade on?
Roivant Sciences Ltd. - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Roivant Sciences Ltd. - Common Shares?
The ticker symbol for Roivant Sciences Ltd. - Common Shares is ROIV on the Nasdaq Stock Market
What is the current price of Roivant Sciences Ltd. - Common Shares?
The current price of Roivant Sciences Ltd. - Common Shares is 26.52
When was Roivant Sciences Ltd. - Common Shares last traded?
The last trade of Roivant Sciences Ltd. - Common Shares was at 03/27/26 04:00 PM ET
What is the market capitalization of Roivant Sciences Ltd. - Common Shares?
The market capitalization of Roivant Sciences Ltd. - Common Shares is 18.35B
How many shares of Roivant Sciences Ltd. - Common Shares are outstanding?
Roivant Sciences Ltd. - Common Shares has 18B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
